APOA1 and amyotrophic lateral sclerosis: Although confirmation of cholesterol levels in ALS mice before and after ApoA1 treatment is needed and will be addressed in our future study, beneficial protein treatment effects augment delayed disease progression and motor neuron survival in G93A SOD1 mice of both genders.